Liver Cancer Trial, Recruiting (NCT04348838)

Liver Cancer Trial, Recruiting NCT04348838 Sponsor: Centre Hospitalier Universitaire, Amiens Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04348838 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been newly diagnosed with hepatocellular carcinoma (a type of liver cancer)
People with a suspected case of this type of liver cancer, regardless of the cause, stage, or treatment involved
People with a known diagnosis of this liver cancer who are receiving medication for a recurrence or worsening of the disease

Who may not be able to join:

People who have a serious condition, separate from liver disease, that is considered life-threatening in the near term
People under 18 years of age, people under a legal guardianship order, or people whose freedom has been restricted by an administrative or legal decision

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jean-Claude BARBARE, Pr, CHU Amiens

Phone: (33)322668193

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04348838

Sponsor: Centre Hospitalier Universitaire, Amiens

Phase: Not Applicable

Status: Recruiting

Condition: Liver Cancer

Trial contact: (33)322668193

More information: https://clinicaltrials.gov/study/NCT04348838

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been newly diagnosed with hepatocellular carcinoma (a type of liver cancer)
People with a suspected case of this type of liver cancer, regardless of the cause, stage, or treatment involved
People with a known diagnosis of this liver cancer who are receiving medication for a recurrence or worsening of the disease

Who may not be able to join:

People who have a serious condition, separate from liver disease, that is considered life-threatening in the near term
People under 18 years of age, people under a legal guardianship order, or people whose freedom has been restricted by an administrative or legal decision

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier Universitaire, Amiens

Registry

ClinicalTrials.gov

Start date

26 September 2019

Est. completion

30 September 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Variation of progression free survival (PFS) in intent to treat after liver transplantation; Variation of time until failure of the strategy after hepatic resection and percutaneous destruction; Variation of overall survival time (OS) after chemoembolization; Variation of overall survival time (OS) after radioembolization; Variation of overall survival time (OS) after pharmaceutical treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov